130 related articles for article (PubMed ID: 9620417)
1. Low-level vancomycin resistance in Clostridium innocuum.
Mory F; Lozniewski A; David V; Carlier JP; Dubreuil L; Leclercq R
J Clin Microbiol; 1998 Jun; 36(6):1767-8. PubMed ID: 9620417
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococci.
Hanaki H; Yamaguchi Y; Nomura S; Nagayama A; Sunakawa K
Int J Antimicrob Agents; 2004 May; 23(5):502-5. PubMed ID: 15120731
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.
Ribeiro T; Abrantes M; Lopes Mde F; Crespo MT
Int J Food Microbiol; 2007 Feb; 113(3):289-95. PubMed ID: 17140688
[TBL] [Abstract][Full Text] [Related]
4. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE
Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765
[TBL] [Abstract][Full Text] [Related]
5. Clostridium innocuum is a significant vancomycin-resistant pathogen for extraintestinal clostridial infection.
Chia JH; Feng Y; Su LH; Wu TL; Chen CL; Liang YH; Chiu CH
Clin Microbiol Infect; 2017 Aug; 23(8):560-566. PubMed ID: 28254687
[TBL] [Abstract][Full Text] [Related]
6. Detection of clinical vancomycin-resistant enterococci in Denmark by multiplex PCR and sandwich hybridization.
Poulsen RL; Pallesen LV; Frimodt-Møller N; Espersen F
APMIS; 1999 Apr; 107(4):404-12. PubMed ID: 10230695
[TBL] [Abstract][Full Text] [Related]
7. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
Bell JM; Paton JC; Turnidge J
J Clin Microbiol; 1998 Aug; 36(8):2187-90. PubMed ID: 9665988
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
Biavasco F; Vignaroli C; Lupidi R; Manso E; Facinelli B; Varaldo PE
Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
Szűcs Z; Bereczki I; Csávás M; Rőth E; Borbás A; Batta G; Ostorházi E; Szatmári R; Herczegh P
J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
[TBL] [Abstract][Full Text] [Related]
11. Clostridium innocuum is a vancomycin-resistant pathogen that may cause antibiotic-associated diarrhoea.
Chia JH; Wu TS; Wu TL; Chen CL; Chuang CH; Su LH; Chang HJ; Lu CC; Kuo AJ; Lai HC; Chiu CH
Clin Microbiol Infect; 2018 Nov; 24(11):1195-1199. PubMed ID: 29458157
[TBL] [Abstract][Full Text] [Related]
12. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
13. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.
Fines M; Perichon B; Reynolds P; Sahm DF; Courvalin P
Antimicrob Agents Chemother; 1999 Sep; 43(9):2161-4. PubMed ID: 10471558
[TBL] [Abstract][Full Text] [Related]
14. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum.
Power EG; Abdulla YH; Talsania HG; Spice W; Aathithan S; French GL
J Antimicrob Chemother; 1995 Oct; 36(4):595-606. PubMed ID: 8591934
[TBL] [Abstract][Full Text] [Related]
15. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
16. Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens.
Alexander CJ; Citron DM; Brazier JS; Goldstein EJ
J Clin Microbiol; 1995 Dec; 33(12):3209-15. PubMed ID: 8586704
[TBL] [Abstract][Full Text] [Related]
17. vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546.
Gagnon S; Lévesque S; Lefebvre B; Bourgault AM; Labbé AC; Roger M
J Antimicrob Chemother; 2011 Dec; 66(12):2758-62. PubMed ID: 21926081
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.
Pantosti A; Luzzi I; Cardines R; Gianfrilli P
Antimicrob Agents Chemother; 1985 Dec; 28(6):847-8. PubMed ID: 2935077
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of the vancomycin-resistant genes vanA, vanB, vanCl, vanC2 and vanC3 in Enterococcus strains isolated from poultry and pork.
Lemcke R; Bülte M
Int J Food Microbiol; 2000 Sep; 60(2-3):185-94. PubMed ID: 11016608
[TBL] [Abstract][Full Text] [Related]
20. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
